Published online May 26, 2021. doi: 10.12998/wjcc.v9.i15.3765
Peer-review started: January 9, 2021
First decision: February 12, 2021
Revised: February 15, 2021
Accepted: March 8, 2021
Article in press: March 8, 2021
Published online: May 26, 2021
Processing time: 121 Days and 23.7 Hours
Liver transplantation (LT) is the most effective treatment strategy for advanced liver diseases. With the increasing survival rate and prolonged survival time, the postoperative long-term complications of LT recipients are becoming an important concern. Among them, the newly developed cancer after LT is the second complication and cause of LT-related death after cardiovascular disease. At present, few papers have reported multiple primary carcinomas (MPCs) after LT. Herein, we retrospectively analyzed an MPC case with gastric cancer and lung cancer after LT.
Herein, we retrospectively analyzed an MPC case with de novo gastric cancer and lung cancer after LT with no obvious complaints. Forty-one months after LT, the patient underwent radical distal gastrectomy (Billroth II) for intramucosal signet ring cell carcinoma, and then thoracoscopic wedge resection of the right lower lobe of the right lung and localized lymph node dissection 2 mo later. Therefore, paying attention to follow-up in LT recipients with early detection and intervention of de novo MPCs is the key to improving the survival rate and quality of life of LT recipients.
De novo MPCs after LT are rare, and the prognosis is poorer. However, early detection and related intervention can significantly improve the prognosis of patients. Therefore, we recommend that liver transplant recipients should be followed and screened for newly developed malignant tumors to improve the survival rate and quality of life.
Core Tip: Few papers have reported de novo multiple primary carcinomas (MPCs) after liver transplantation (LT) yet. Herein, we retrospectively analyzed an MPC case with gastric cancer and lung cancer after LT. Forty-one months after LT, the patient underwent radical distal gastrectomy for a de novo intramucosal signet ring cell carcinoma in the stomach. Two months later, the patient underwent thoracoscopic wedge resection of the right lower lobe of the right lung for the de novo lung cancer. The patient has survived till now with stable function of the graft. Early diagnosis and early treatment of de novo MPCs are the keys to improving the survival rate and quality of life of LT recipients with de novo MPCs.